28 September 2012
Egorov Puginsky Afanasiev & Partners' Litigation Practice Lawyers successfully defend a major Russian Pharmaceutical Holding

Litigation practice lawyers from Egorov Puginsky Afanasiev & Partners successfully defended BIOTEK, a major Russian pharmaceutical holding, in a challenging an IP dispute.

On September 26, 2012, the Federal Arbitrazh Court for the Moscow District dismissed a cassation appeal filed by F. Hoffmann - La Roche AG that sought the reversal of judgments previously granted to the Firm’s client.

F. Hoffmann - La Roche AG alleged that BIOTEK had infringed on its patented invention rights and sought a freezing order to ban sales of oncology medication Tutabin. Following an in-depth study of the issue, the Firm’s experts could formulate a legal position that convinced the court that the plaintiff’s patent rights were not infringed upon as the medication did not accommodate every feature of F. Hoffmann - La Roche AG invention.

The client was represented by Partner Denis Arkhipov, together with associates Denis Golubev and Olga Semushina.

PRACTICE AREAS

KEY CONTACTS

Denis Arkhipov

Denis Arkhipov

Moscow, Limassol

Denis Golubev

Denis Golubev

Moscow